![]() |
Volumn 6, Issue 4, 2000, Pages 378-379
|
Will therapeutic peptides be kryptonite for superantigens?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B7 ANTIGEN;
CD28 ANTIGEN;
EXOTOXIN;
GAMMA INTERFERON;
INTERLEUKIN 1;
INTERLEUKIN 2;
LYMPHOTOXIN;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
NEUTRALIZING ANTIBODY;
POLYPEPTIDE;
SUPERANTIGEN;
T LYMPHOCYTE RECEPTOR;
TUMOR NECROSIS FACTOR ALPHA;
ANTIBODY RESPONSE;
ANTIGEN PRESENTING CELL;
CELLULAR IMMUNITY;
CONFUSION;
CYTOKINE RELEASE;
DIARRHEA;
ERYTHEMA;
FATALITY;
FEVER;
HUMAN;
HYPERTENSION;
NECROTIZING FASCIITIS;
NONHUMAN;
PRIORITY JOURNAL;
SHOCK;
SHORT SURVEY;
SKIN EXFOLIATION;
SORE THROAT;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PYOGENES;
T LYMPHOCYTE;
TOXIC SHOCK SYNDROME;
VOMITING;
ANIMALS;
CYTOKINES;
ENTEROTOXINS;
HUMANS;
OLIGOPEPTIDES;
SHOCK, SEPTIC;
STAPHYLOCOCCUS AUREUS;
SUPERANTIGENS;
BACTERIA (MICROORGANISMS);
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PYOGENES;
|
EID: 0034117475
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/74630 Document Type: Short Survey |
Times cited : (8)
|
References (10)
|